{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:35:28Z","timestamp":1761510928133,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.tmaid.2009.07.001","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T06:04:03Z","timestamp":1250057043000},"page":"231-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serogroup B meningococcal disease during Hajj: Preparing for the worst scenario"],"prefix":"10.1016","volume":"7","author":[{"given":"Mohamed K.M.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2009.07.001_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.meegid.2008.04.002","article-title":"Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease","volume":"8","author":"Caugant","year":"2008","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.tmaid.2009.07.001_bib2","series-title":"Principles and practice of infectious diseases","first-page":"2228","article-title":"Neisseria meningitidis","author":"Apicella","year":"2000"},{"key":"10.1016\/j.tmaid.2009.07.001_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tmaid.2007.10.002","article-title":"Meningococcal disease: risk for international travelers and vaccine strategies","volume":"6","author":"Wilder-Smith","year":"2008","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1017\/S0950268807008825","article-title":"The changing face of meningococcal disease in West Africa","volume":"135","author":"Greenwood","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2009.07.001_bib5","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/iai.60.12.5267-5282.1992","article-title":"Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China","volume":"60","author":"Wang","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.tmaid.2009.07.001_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2009.07.001_bib7","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"105","key":"10.1016\/j.tmaid.2009.07.001_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0950268800047713","article-title":"Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile","volume":"1990","author":"Cruz","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2009.07.001_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/517385","article-title":"New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4","volume":"177","author":"Martin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JCM.39.7.2695-2699.2001","article-title":"Comparison of serogroup W135 meningococci isolated in Sweden during\u00a0a 23-year period and those associated with a recent Hajj pilgrimage","volume":"39","author":"Molding","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2009.07.001_bib11","first-page":"1410","article-title":"Changes in epidemiological pattern of meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control?","volume":"25","author":"Al-Mazrou","year":"2004","journal-title":"Saudi Med J"},{"key":"10.1016\/j.tmaid.2009.07.001_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/367858","article-title":"Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers","volume":"36","author":"Wilder-Smith","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0924-8579(02)00356-4","article-title":"Meningococcal carriage among local inhabitants during the pilgrimage 2000\u20132001","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2009.07.001_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00365540410020082","article-title":"Neisseria meningitidis W-135 carriage during the Hajj season 2003","volume":"36","author":"Balkhy","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib16","first-page":"3","article-title":"Clinical and microbiological spectrum of meningococcal disease in adults during Hajj 2000: an implication of quadrivalent vaccination policy","volume":"53","author":"Karima","year":"2003","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.tmaid.2009.07.001_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0950268800004805","article-title":"Determinants of case fatality rates of meningococcal disease during outbreaks in Makkah, Saudi Arabia, 1987\u201397","volume":"125","author":"El Bushra","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2009.07.001_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2009.07.001_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2009.07.001_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2009.07.001_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.inf.0000258697.05341.2c","article-title":"New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16\u201324 months","volume":"26","author":"Wong","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2009.07.001_bib22","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2009.07.001_bib23","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tmaid.2009.07.001_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.tmaid.2009.07.001_bib25","unstructured":"Miller E, Pollard AJ, Borrow R, Findlow J, Dawson T, Morant A, et\u00a0al. Safety and immunogenicity of Novartis meningococcal serogroup B vaccine after three doses administered in infancy. In: 26th Meeting of the European Society for Paediatric Infectious Diseases \u2013 ESPID, Graz, Austria, 14th May 2008."},{"key":"10.1016\/j.tmaid.2009.07.001_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinids\/17.1.126","article-title":"Forty years of meningococcal disease in Israel: 1951\u20131990","volume":"17","author":"Block","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib27","first-page":"221","article-title":"[Meningococcal disease in western Galilee]","volume":"122","author":"Greif","year":"1992","journal-title":"Harefuah"},{"key":"10.1016\/j.tmaid.2009.07.001_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1017\/S0950268807009259","article-title":"Invasive meningococcal disease in children in Jerusalem","volume":"136","author":"Stein-Zamir","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2009.07.001_bib29","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal diseases","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2009.07.001_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(06)68429-8","article-title":"Health risks at the Hajj","volume":"367","author":"Ahmed","year":"2006","journal-title":"Lancet"},{"year":"2009","series-title":"Tourism statistics 2007","key":"10.1016\/j.tmaid.2009.07.001_bib31"},{"key":"10.1016\/j.tmaid.2009.07.001_bib32","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.vaccine.2005.01.084","article-title":"The changing epidemiology of meningococcal meningitis after introduction of bivalent A\/C polysaccharide vaccine into school-based vaccination program in Egypt","volume":"23","author":"Nakhla","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2009.07.001_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-007-0280-x","article-title":"Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998\u20132004)","volume":"26","author":"Afifi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2009.07.001_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3201\/eid1407.070938","article-title":"A prospective study of etiology of childhood acute bacterial meningitis, Turkey","volume":"14","author":"Ceyhan","year":"2008","journal-title":"Emerg Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893909001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893909001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:57:48Z","timestamp":1761487068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893909001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1477893909001203"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2009.07.001","relation":{},"ISSN":["1477-8939"],"issn-type":[{"type":"print","value":"1477-8939"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serogroup B meningococcal disease during Hajj: Preparing for the worst scenario","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2009.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}